John W Smither Genelux Corp (GNLX) insider trading activity

GNLX Quotes by TradingView
Shares Held (Direct Ownership) 52.7K
0% 3M change
661.72% 12M change
Total Value Held N/A

John W Smither Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
BUY
Grant, award, or other acquisition
-
39,541 Added 42.86%
52,711 Common Stock
May 29 2024
BUY
Open market or private purchase
-
6,250 Added 32.18%
13,170 Common Stock
Sep 13 2023
SELL
Open market or private sale
$18,702 $20.78 p/Share
900 Reduced 11.51%
6,920 Common Stock
Sep 11 2023
BUY
Grant, award, or other acquisition
-
6,920 Added 46.95%
7,820 Common Stock

Also insider at

ARQT
Arcutis Biotherapeutics, Inc. Healthcare
Chief Financial Officer
EFTR
eFFECTOR Therapeutics, Inc. Healthcare
Director
AMTI
Applied Molecular Transport Inc. Healthcare
Director
NAMS
NewAmsterdam Pharma Co N.V.
JWS

John W Smither

Solana Beach, CA

Track Institutional and Insider Activities on GNLX

Follow GENELUX CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GNLX shares.

Notify only if

Insider Trading

Get notified when an Genelux Corp insider buys or sells GNLX shares.

Notify only if

News

Receive news related to GENELUX CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GNLX